Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1EUROAPI
03 1LGM Pharma
04 1Transo-Pharm Handels GmbH
05 1Jai Radhe Sales
06 1Moehs Iberica
07 1Amuna Pharmaceuticals
08 1Anvitha Lifecare
09 1Beijing Fukangren Biopharmaceutical
10 2Cambrex Corporation
11 1ChemPacific Corp
12 1Curia
13 1Hameln rds
14 1Hanways Chempharm
15 1Harman Finochem
16 1Hunan Warrant Chiral Pharmaceutical
17 1Mac-Chem Products (India) Pvt.Ltd
18 1Medinex Laboratories
19 1Recipharm AB
20 1Shenzhen Oriental Pharmaceutical
21 1Sun Pharmaceutical Industries Limited
22 1Surajlok Chemicals
23 1Wuhan Wuyao Pharmaceutical
24 1Blank
01 5China
02 1France
03 1Germany
04 8India
05 1Slovakia
06 1Spain
07 1Sweden
08 6U.S.A
09 1Blank
01 6Active
02 2Inactive
03 17Blank
01 7Valid
02 1Withdrawn by EDQM Failure to CEP procedure
03 17Blank
01 25Blank
01 1WC-0044
02 1WC-0168
03 1WC-0279
04 1WC-0435a
05 21Blank
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
Certificate Number : R1-CEP 2004-312 - Rev 01
Issue Date : 2021-12-10
Type : Chemical
Substance Number : 285
Status : Valid
Available Reg Filing : ROW |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-11-19
Pay. Date : 2019-09-19
DMF Number : 33127
Submission : 2018-09-30
Status : Active
Type : II
Certificate Number : R0-CEP 2022-253 - Rev 00
Issue Date : 2023-08-08
Type : Chemical
Substance Number : 285
Status : Valid
Date of Issue : 2022-06-06
Valid Till : 2025-07-21
Written Confirmation Number : WC-0044
Address of the Firm :
NDC Package Code : 66064-1025
Start Marketing Date : 2017-02-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35184
Submission : 2021-02-22
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-09-04
Pay. Date : 2019-07-11
DMF Number : 34008
Submission : 2019-07-31
Status : Active
Type : II
Certificate Number : R0-CEP 2020-089 - Rev 00
Issue Date : 2021-06-08
Type : Chemical
Substance Number : 285
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15367
Submission : 2001-03-30
Status : Inactive
Type : II
Certificate Number : R1-CEP 2014-316 - Rev 01
Issue Date : 2022-07-15
Type : Chemical
Substance Number : 285
Status : Valid
NDC Package Code : 65832-0001
Start Marketing Date : 2011-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hyons Co., Ltd.
Registration Date : 2022-06-08
Registration Number : 20210420-210-J-944(2)
Manufacturer Name : Wuhan Wuyao Pharmaceutical Co., LTD.
Manufacturer Address : No.18, Wangfen Road, Fuchi Town, Yangxin County, Huangshi City, Hubei Province, China
We have 23 companies offering Norepinephrine Bitartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?